This started inside a family, not in a pitch.
Aura was born from breast cancer in the founder's family. From the paperwork, the mixed-up schedules, the appointment where nobody could remember exactly when the fever had started. The conclusion was simple and uncomfortable: the hospital keeps what it saw, but what the patient lives between appointments is kept nowhere.
No product decision goes in without a physician from the field reviewing it. Not as an occasional consultant — as a partner.
- 2024
The notebook in the drawer
The treatment routine was written down by hand and rebuilt from memory at the next appointment.
- 2025
First prototype
Doses, symptoms and tests in one place, tested with real patients and a breast specialist alongside.
- 2026
Aura Onco goes live
The app on both stores, a dashboard for institutions, and care pilots under evaluation.
- Next
Other modules
Cardiology, chronic conditions and pregnancy — the same foundation, different specialties.
“Nobody should have to remember by heart how the three weeks at home went.”
Who answers for this.
Product and clinical care at the same table. Our medical registrations (CRM) are public because, in healthcare, that is not a detail.
Matheus Celso
FounderConceived Aura from a family experience with breast cancer and the need to organise the patient's care.
Dr. Daniel Castro
Partner · Breast specialist · CRM/PR 27339Clinical lead. Surgical oncology (RQE 1873 · 19406) — makes sure every product decision is safe and true to the reality of care.
Dr. Fernando Motter
Oncologist · CRM/PR 22436Clinical oncology, chemotherapy and immunotherapy. Technical director at OncoMedi, bringing the treatment perspective into the platform.
Four rules we don't negotiate.
They settle product discussions every week — including against features that would sell better.
- 01
The account belongs to the patient
The app works without a hospital. Connecting is her choice, and she can undo it at any time.
- 02
Support, never diagnosis
We organise information and make the conversation easier. Clinical decisions belong to the team.
- 03
No guilt
No streaks, no nagging. Someone in chemotherapy does not need one more goal.
- 04
Data under the LGPD
Database in Brazil and access isolated by institution. Whatever is processed outside Brazil is listed in the policy, processor by processor.
- 4
clinical modules planned — oncology is the first one live
- 2
responsible physicians, with public CRM registrations, as partners in the company
- 0
data sold to third parties — it is not part of the model